Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 14,496 Castle Biosciences, Inc. shares (Form 4)

Traded Oct 5, 2026 · Filed Oct 7, 2026

On Oct 5, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 14,496 Castle Biosciences, Inc. shares at US$35.57 for US$516K under a trading plan, leaving 6,832 shares. Filed Oct 7, 2026 (Form 4).

Sold
14,496 shares
Price
US$35.57
Value
US$516K
Holding after
6,832 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 5, 2026Common StockOption exercise8,165US$2.3929,644Direct
Oct 5, 2026Common StockSale8,580US$35.5721,064Direct
Oct 5, 2026Common StockSale3,198US$35.578,038Indirect
Oct 5, 2026Common StockSale2,718US$35.576,832Indirect

Source

View original at SEC

Related